The reinforcing effects of ethanol within the nucleus accumbens shell involve activation of local GABA and serotonin receptors by Ding, Zheng-Ming et al.
 1 
The reinforcing effects of ethanol within the nucleus accumbens shell involve activation of 
local GABA and serotonin receptors 
 
Zheng-Ming Ding*, Cynthia M. Ingraham, Zachary A. Rodd, William J. McBride 
 
Institute of Psychiatric Research, Department of Psychiatry, Indiana University School of 
Medicine, Indianapolis, IN 46202 
 
* Address correspondence to: 
Zheng-Ming Ding, Neuroscience Research Building, Department of Psychiatry, Indiana 
University School of Medicine, 320 W. 15th Street, NB300A, Indianapolis, IN 46202-2266 USA 
Phone: 317-274-2336; Fax: 317-231-0202; E-mail: zding@iupui.edu 
 
 
 
 
 
 
 
 
 
This is the author's manuscript of the article published in final edited form as: 
 
Ding, Z.-M., Ingraham, C. M., Rodd, Z. A., & McBride, W. J. (2015). The reinforcing effects of ethanol within 
the nucleus accumbens shell involve activation of local GABA and serotonin receptors. Journal of 
Psychopharmacology, 29(6), 725–733. http://doi.org/10.1177/0269881115581982  
 2 
Abstract 
Ethanol is reinforcing within the nucleus accumbens shell (NACsh), but the underlying 
mechanisms remain unclear. Ethanol can potentiate the function of the GABAA, GABAB, and 5-
HT3 receptors. Therefore, the current study tested the hypothesis that activation of these 
receptors would be involved in the reinforcing effects of ethanol in the NACsh. An intracranial 
self-administration (ICSA) procedure was used to assess the reinforcing effects of ethanol in the 
NACsh of alcohol preferring (P) rats. The ICSA consisted of 7 sessions: 4 sessions to establish 
150 mg% ethanol self-infusion into the NACsh; sessions 5 and 6 with co-infusion of ethanol plus 
one concentration of the GABAA antagonist bicuculline (10 or 100 µM), the GABAB antagonist 
SCH 50911 (50, 75 or 100 µM), or the 5-HT3 receptor antagonist zacopride (10 or 100 µM); and 
session 7 with 150 mg% ethanol alone. All groups self-infused ethanol into the NACsh and 
readily discriminated the active from inactive lever during the acquisition sessions. Co-infusion 
of 100 µM, but not 10 µM, bicuculline or zacopride significantly decreased active responses 
during sessions 5 and 6. Co-infusion of 75 µM, but not 50 or 100 µM, SCH 50911 significantly 
attenuated responses for ethanol. Overall, the results suggest that the reinforcing effects of 
ethanol in the NACsh may be modulated by activation of local GABAA, GABAB and 5-HT3 
receptors.  
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Introduction 
Identification of brain reward mechanisms underlying the reinforcing effects of ethanol is 
critical to the development of effective therapies for combating alcohol abuse and alcoholism. A 
recent intracranial self-administration (ICSA) study demonstrated that ethanol can be readily 
self-infused into the nucleus accumbens (NAC) of the rat; the self-infusion was sub-region 
dependent with self-infusion into the NAC shell (NACsh) but not NAC core (NACcr), and 
genetically influenced with alcohol preferring (P) rats being more sensitive than stock Wistar rats 
to the rewarding effects of ethanol (Engleman et al. 2009). These findings suggest that the 
NACsh is one neuro-anatomical substrate supporting the reinforcing and rewarding effects of 
ethanol. However, neurochemical mechanisms underlying these effects remain unknown and 
elucidation of such mechanisms are important.  
The NAC is a heterogeneous nucleus and approximately 90% of its neurons are 
GABAergic medium spiny neurons (MSNs); it receives synaptic inputs from various brain 
regions (Meredith 1999; Sesack and Grace 2010). GABA synapses provide a major inhibitory 
regulation of MSN activity. These GABAergic inputs originate mainly from GABA neurons in 
the VTA (Van Bockstaele and Pickel 1995) and ventral pallidum (Groenewegen et al. 1999), as 
well as intrinsic axonal collaterals from local MSNs (Meredith 1999). Moderate expression of 
both GABAA and GABAB receptors were found in the NAC (Bowery et al. 1987; Schwarzer et 
al. 2001). In addition, the NAC receives modulatory serotonin (5-HT) afferents from the dorsal 
raphe nucleus (Van Bockstaele and Pickel 1993). The presence of 5-HT receptors has been 
demonstrated in the NAC (Meredith 1999), including the serotonin-3 (5-HT3) receptor (Ge et al. 
1997). The interactions between GABA/5-HT and their respective receptors play an important 
role in regulating the MSN activity and other neurotransmitter systems converging on the NAC 
 4 
(Meredith 1999). It has been proposed that the rewarding information is encoded in the activity 
of MSNs in the NAC and forwarded to downstream structures including the ventral pallidum 
(Carlezon and Thomas 2009).  
Substantial evidence suggests that GABA neurotransmission is involved in the effects of 
ethanol (Koob 2004). Electrophysiological studies indicate that acute ethanol can potentiate 
GABAA- and GABAB- receptor mediated inhibitory currents (Allan et al. 1987; Federici et al. 
2009; Grobin et al. 1998). Systemic administration of GABAA receptor antagonists or an inverse 
benzodiazepine agonist reduced voluntary alcohol drinking and the motivation in rats to respond 
for ethanol self-administration in an oral operant setting (McBride et al. 1988; Petry 1997; 
Rassnick et al. 1993; Samson et al. 1987). GABAA receptors within the mesolimbic system 
appeared to mediate such effects (Hodge et al. 1995; Hyytia and Koob 1995). Similarly, 
pharmacological manipulations of GABAB receptor activity can regulate the reinforcing and 
rewarding effects of ethanol (Maccioni and Colombo 2009; Vlachou and Markou 2010). In 
addition, acute ethanol can facilitate 5-HT3 receptor-mediated ion currents (Lovinger and White 
1991). The 5-HT3 receptor has been implicated in the effects of drugs of abuse (Engleman et al. 
2008). Systemic administration of 5-HT3 receptor antagonists suppressed voluntary ethanol 
consumption in rats under 24-hr free-choice conditions (Knapp and Pohorecky 1992; McKinzie 
et al. 1998). Nonetheless, the involvement of these receptors in the local reinforcing effects of 
ethanol within the NACsh has not been examined. Given the above-mentioned findings, it is 
possible that activation of these receptors may be involved in mediating the self-infusion of 
ethanol into the NACsh. The current study was designed to test this hypothesis by examining 
local self-infusion of ethanol in the presence of antagonists for these receptors. 
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Materials and methods 
Animals: Experimentally-naïve adult female alcohol preferring (P) rats (body weight 250 
to 300 g, Indiana University) were housed in-pairs in a reverse 12-hr light-dark cycle room (light 
off at 10:00 am) with temperature and humidity maintained constant for at least 2 weeks before 
the commencement of experiment. Food and water were available ad libitum except during the 
ICSA test sessions. Female rats were used in the present study due to their ability to maintain 
their head size better than male rats for more accurate stereotaxic placements (Ding et al. 2009; 
Rodd-Henricks et al. 2000a). The estrous cycle was not monitored in the present study. 
Experiments were performed during the dark phase. Protocols used were approved by the 
Institutional Animal Care and Use Committee of Indiana University School of Medicine. All 
experiments were performed in accordance with the principles outlined in the Guide for the Care 
and Use of Laboratory Animals (National Research Council, 2011). 
Chemical agents: The artificial cerebrospinal fluid (aCSF) consisted of 120 mM NaCl, 
4.8 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 25 mM NaHCO3, 1.2 mM CaCl2, 10 mM d-
glucose, pH 7.2-7.4. Ethyl alcohol (190 proof) was obtained from Decon Laboratories, Inc, 
(King of Prussia, PA). The GABAA receptor antagonist bicuculline, the GABAB receptor 
antagonist SCH 50911 (Bolser et al. 1995), and the 5-HT3 receptor antagonist zacopride were 
obtained from Tocris (Ellisville, MO). All chemicals were dissolved in the aCSF solution to the 
desired concentrations prior to use. 
Stereotaxic surgery procedures: Rats were implanted unilaterally with a 22-gauge 
cannula (Plastics One Inc., Roanoke, VA) aimed at the right NACsh (AP + 1.7 mm, ML + 2.4 
mm, DV – 7.0 mm), as described previously (Engleman et al. 2009). Stylets were inserted into 
cannulae when no experiments were being conducted. Rats were individually housed after 
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surgery and were allowed to recover from surgery for at least 7 days prior to tests. Rats were 
habituated and handled on a daily basis during the 7-day period.  
Intracranial self-administration (ICSA) procedure: The ICSA tests followed 
procedures previously described (Ding et al. 2009; Engleman et al. 2009). Briefly, rats were 
placed into standard two-lever operant chambers on test days. One active lever was connected to 
an isolated pulse stimulator (A-M Systems, Inc, Carlsborg, WA) controlled by an operant control 
system Graphic State 3.02 (Coulbourn Instruments, Allentown, PA). The pulse stimulator was 
connected to two electrodes that were immersed in a drug-filled tank equipped with a 28-gauge 
injection cannula inserted into the NACsh. Each response on the active lever (FR1 reinforcement 
schedule) produced a pulse infusion of 100 nl of solution into the NACsh during a 5-sec period. 
Each infusion was followed by a 5-sec timeout period. During both the infusion and timeout 
periods, responses on the active lever were recorded but did not produce further infusions. The 
responses on the inactive lever were recorded but did not result in any infusions. The assignment 
of active and inactive lever was counterbalanced among rats.  
There were a total of 7 sessions conducted every other day with the duration of each 
session being 4 hr. The first four sessions were acquisition sessions with 150 mg% ethanol 
available for self-infusion for each rat. This concentration of ethanol is physiologically relevant 
and can be readily achieved with free-choice voluntary drinking by P rats (Murphy et al., 1986). 
In addition, this concentration of ethanol was demonstrated to be the optimal concentration for 
self-infusion into the NACsh by P rats (Engleman et al. 2009). Sessions 5 and 6 were co-infusion 
sessions, during which 150 mg% ethanol plus one concentration of the GABAA antagonist 
bicuculline (10 or 100 µM), the GABAB receptor antagonist SCH 50911 (50, 75 or 100 µM), or 
the 5-HT3 receptor antagonist zacopride (10 or 100 µM) was self-infused. Session 7 was a 
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session with the return of self-infusion of only 150 mg% ethanol. This procedure has been 
carried out in the past to examine receptor mechanisms involved in ethanol ICSA within the 
posterior VTA (Ding et al. 2012; Rodd-Henricks et al. 2003). In addition, the Engleman et al. 
study (2009) showed that replacement of ethanol with aCSF during sessions 5 & 6 resulted in 
extinction of lever responding. Therefore, such a group was not included in the current study.  
Histology: At the end of the experiments, rats were euthanized and bromophenol blue 
was injected into the NACsh, as described previously (Engleman et al. 2009). Brains were 
quickly removed and frozen at -20 oC. Brain sections (40 µm thick) were sliced in a cryostat 
microtome and stained with cresyl violet for the verification of the placement of injection sites 
according to the rat brain atlas of Paxinos & Watson (Paxinos and Watson 1998). 
Statistical analysis: For each group, lever discrimination was determined by ‘lever 
(active vs inactive) x session’ mixed ANOVA with repeated measures on session; t-tests were 
used to compare responses between active and inactive lever following a significant main effect 
(p < 0.05). For determination of drug effect, paired t-tests were used to compare the responses on 
the active lever and number of infusions during sessions 5 and 6 to average responses on the 
active lever and number of infusions during acquisition sessions 3 and 4.  
 
Results 
Figure 1 depicts the representative non-overlapping placements of injection sites within 
the NACsh. A majority of injection sites were located in the medial and ventral portions of the 
NACsh. Only rats with correct placements in the NACsh were included in analysis. There were 
six rats with injection sites ventral to the NACsh (Fig. 1). These rats displayed low responses on 
active and inactive levers (8 ± 2 vs 5 ± 1 responses/session, respectively), as well as low 
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infusions per session (5 ±1). These results, along with the previous study (Engleman et al., 2009), 
suggest that adjacent areas outside the NACsh do not support the self-infusion of ethanol.     
Lever responses for the bicuculline co-infusion groups are shown in Fig. 2. The ‘lever x 
session’ mixed ANOVAs indicated that the control group (Fig. 2, upper panel) demonstrated a 
significant effect of lever (F 1, 12 = 20.3, p = 0.001) and interaction (F 6, 72 = 2.8, p = 0.02), but no 
effect of session (F 6, 72 = 1.3, p = 0.28). Lever discrimination was observed during sessions 3 
through 7. The 10 µM bicuculline group demonstrated significant effects of session (F 6, 60 = 5.3, 
p < 0.001), lever (F 1, 10 = 21.2, p = 0.001) and interaction (F 6, 60 = 2.5, p = 0.03).  Lever 
discrimination was observed during each session. Microinjection of 10 µM bicuculline did not 
significantly reduce responses on the active lever (Fig. 2,  middle panel, e.g., responses in 
session 6 vs average during sessions 3 & 4: 36 ± 6 vs 42 ± 5, t5 = 0.9, p = 0.39) or number of 
infusions (Table 1) during either treatment session. The significant effects of session and 
interaction resulted mainly from the significant difference in responses on the active lever 
between session one and the other sessions. The 100 µM bicuculline group (Fig. 2, bottom panel) 
demonstrated significant effects of session (F 6, 60 = 11.7, p < 0.001), lever (F 1, 10 = 21.2, p = 
0.001), and interaction (F 6, 60 = 9.0, p < 0.001).  Lever discrimination was evident during 
sessions 1 to 4, and session 7. Co-infusion of 100 µM bicuculline with ethanol significantly 
depressed responses on the active lever (e.g., responses in session 6 vs average during sessions 3 
& 4: 13 ± 3 vs 35 ± 2, t5 = 7.4, p = 0.001) and number of infusions (Table 1) during both 
treatment sessions. Responses on the active lever during session 7 returned to levels observed 
during the acquisition sessions.  
Lever responses in the SCH 50911 co-infusion groups are shown in Fig. 3. The 50 µM 
SCH 50911 group (Fig. 3, upper panel) demonstrated significant effects of session (F 6, 60 = 4.7, p 
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= 0.001), lever (F 1, 10 = 13.8, p = 0.004) and interaction (F 6, 60 = 2.5, p = 0.03). Lever 
discrimination was observed during sessions 3 to 5, and 7. SCH 50911 at 50 µM slightly reduced 
active responses during session 6. The 75 µM SCH 50911-treated group demonstrated significant 
effects of session (F 6, 60 = 3.8, p = 0.003), lever (F 1, 10 = 8.3, p = 0.02) and interaction (F 6, 60 = 
5.3, p < 0.001).  Lever discrimination was observed during sessions 3, 4, and 7. Co-infusion of 
75 µM SCH 50911 with ethanol significantly depressed responses on the active lever during both 
co-infusion sessions (Fig. 3 middle panel, e.g., responses during session 6 vs average during 
sessions 3 & 4: 13 ± 2 vs 33 ± 4, t5 = 5.3, p = 0.003). The number of infusions was also reduced 
(Table 1). The 100 µM SCH 50911 group (Fig. 3, bottom panel) demonstrated significant effects 
of session (F 6, 60 = 2.9, p = 0.02), lever (F 1, 10 = 18.9, p = 0.001), but no significant effect of 
interaction (F 6, 60 = 0.8, p = 0.79).  Lever discrimination was observed during sessions 3, 4 and 
7. Co-infusion of 100 µM SCH 50911 did not significantly alter responses on the active lever 
during either co-infusion session (e.g., responses during session 6 vs average during sessions 3 
& 4: 36 ±3 vs 49 ± 10, t5 = 1.2, p = 0.29). However, co-infusion of 100 µM SCH 50911 disrupted 
lever discrimination during both treatment sessions, as a result of a trend to increase responses on 
the inactive lever (Fig. 3, bottom panel). 
Lever responses in the zacopride co-infusion groups are shown in Fig. 4. The 10 µM 
zacopride group (Fig. 4, upper panel) demonstrated significant effects of lever (F 1, 12 = 15.58, p 
= 0.002), but no significant effect of session (F 6, 72 = 1.1, p = 0.35) or interaction (F 6, 72 = 0.15, 
p = 0.99). Lever discrimination was observed during sessions 1 to 4, and session 6. Co-infusion 
of 10 µM zacopride did not significantly alter responses on the active lever (e.g., responses 
during session 6 vs average during sessions 3 & 4: 27 ± 5 vs 32 ± 2, t6 = 1.0, p = 0.34) or number 
of infusions (Table 1) in either co-infusion session. The 100 µM zacopride group demonstrated 
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significant effects of session (F 6, 60 = 5.8, p < 0.001), lever (F 1, 10 = 32.3, p < 0.001) and 
interaction (F 6, 60 = 6.3, p < 0.001). Lever discrimination was observed during sessions 2, 3, 4 
and 7. Co-infusion of 100 µM zacopride with ethanol significantly decreased responses on the 
active lever (Fig. 4, bottom panel, e.g., responses during session 6 vs average during sessions 3 
& 4: 16 ± 2 vs 34 ± 3, t5 = 7.1, p = 0.001) and number of infusions (Table 1) during both co-
infusion sessions. Responses on the active lever returned to baseline levels during session 7. 
   
Discussion 
The major findings of the current study are that co-infusion of antagonists for the 
GABAA, GABAB or 5-HT3 receptor with ethanol attenuated the responses on the active lever and 
the self-infusion of ethanol into the NACsh, suggesting that the reinforcing effects of ethanol in 
the NACsh may be mediated, at least in part, by activating local GABAA, GABAB and 5-HT3 
receptors. None of the antagonists, at any concentration, appeared to reduce responses on the 
inactive lever. These results suggest that a general effect of motor impairment cannot account for 
the reduced responses on the active lever. In addition, the highest concentration of the GABAB 
receptor antagonist disrupted lever discrimination mainly by increasing the responses on the 
inactive lever, which suggests a non-specific effect of the antagonist at this concentration.    
The finding with bicuculline is in agreement with previous studies demonstrating that 
both systemic administration (McBride et al. 1988; Petry 1997; Samson et al. 1987) and local 
microinjection of GABAA receptor antagonists into the NACsh (Hyytia and Koob 1995) impaired 
oral ethanol self-administration in the rat. Another study (Hodge et al.1995) also indicated that 
microinjection of bicuculline into the NAC reduced oral ethanol self-administration, although a 
detailed histological map of injection sites was not presented. In addition, bicuculline did not 
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significantly alter responses on the inactive lever (Fig. 2), suggesting the effects of bicuculline 
may not involve alteration of locomotor activity. Moreover, a previous study (Znamensky et al. 
2001) demonstrated that bilateral microinjection of bicuculline (up to 1.6 mM) into the NACsh 
did not significantly alter food intake in the rat, providing support that bicuculline is not 
impairing general motor activity. Taken together, these findings indicate the important role of 
NACsh GABAA receptors in modulating the local positive motivational properties of ethanol 
(Koob 2004). A recent study using a similar ICSA procedure indicated that co-infusion of 
bicuculline with ethanol did not appear to alter ethanol self-infusion directly into the posterior 
VTA (Ding et al. 2011). These results suggest that local GABAA receptors may be differentially 
involved in ethanol self-infusion between the posterior VTA and NACsh.  
In addition, these findings are in line with in vitro electrophysiological studies 
demonstrating that ethanol can potentiate GABAA receptor-mediated currents (Allan et al. 1987). 
In the NAC, ethanol may potentiate GABAA receptor function through both pre- and post-
synaptic mechanisms (Weiner and Valenzuela 2006). In a NAC slice preparation, application of 
ethanol produced a dose-dependent enhancement of GABAA receptor-mediated currents in a 
subpopulation of NAC neurons; the optimal concentration of ethanol (44 mM or ~ 200 mg%) 
was comparable to that used in the current study (150 mg%) and increased GABAA current 
amplitude by approximately 40% in about 45% of neurons examined (Nie et al. 2000). 
Furthermore, ethanol was shown to increase presynaptic GABA release in the NAC slice (Weiner 
and Valenzuela 2006). Therefore, the net effect of ethanol through the GABAA receptor on these 
MSNs may be an enhanced inhibition of their activity and reduce GABA release in the ventral 
pallidum. In line with this idea, previous findings indicated that ethanol administration decreased 
spike activity in approximately 30% of NAC neurons, and reduced extracellular GABA levels in 
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the ventral pallidum (Janak et al. 1999; Kemppainen et al. 2010). It should be noted that the 
exact location of ethanol-sensitive GABAA receptors within the NAC sub-regions remains 
unknown in these electrophysiological studies due to the lack of detailed histological 
presentation of electrode placements. Furthermore, GABAA receptor subunits were also found in 
non-GABAergic interneurons and axonal processes converging on the NAC (Schwarzer et al. 
2001). Activation of these receptors can modulate release of acetylcholine, GABA and/or 
dopamine (Aono et al. 2008; Rada et al. 1993; Yoshida et al. 1997), and differentially alter the 
activity of MSNs. For example, activation of these receptors on GABAergic terminals may 
inhibit GABA release, resulting in attenuated inhibition of post-synaptic MSNs. Indeed, ethanol 
was shown to decrease GABAA-mediated currents and increase the excitability of a 
subpopulation of NAC neurons (Janak et al. 1999; Nie et al. 2000). Moreover, the sensitivity of 
GABAA receptors to ethanol enhancement depends on the subunit compositions of the GABAA 
receptor (Kumar et al. 2009), which are heterogeneously expressed within the NAC (Schwarzer 
et al. 2001). Therefore, the action of ethanol on MSNs depends on micro-circuits within the NAC 
that may differ in the relative location of GABAA receptors and their subunit composition. Taken 
together, it is possible that multiplex mechanisms may contribute to the self-infusion of ethanol 
and the effects of bicuculline on ethanol self-infusion into the NACsh.  
Similar to GABAA receptors, activation of local GABAB receptors appeared to mediate 
the reinforcing effects of ethanol within the NACsh, as indicated by the results that 75 µM SCH 
50911 attenuated ethanol self-infusion. This finding is consistent with in vitro evidence that the 
GABAB receptor-mediated inhibitory postsynaptic potential is sensitive to ethanol potentiation 
(Federici et al. 2009). The highest concentration of SCH 50911 disrupted lever discrimination 
between the active and inactive levers due in part to increased responding on the inactive lever 
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(Fig. 3, bottom panel). These results suggest possible non-specific actions of SCH 50911. The 
mechanism underlying these effects are unknown, but may be due to different subtypes of 
GABAB receptors, GABAB receptors being located on both pre- and post-synaptic membrane, 
and multiple actions of SCH 50911 occurring at the highest concentration. For example, a high 
concentration of SCH 50911 was shown to act as an inverse agonist for the GABAB receptor to 
increase cAMP production in a cell culture (Grunewald et al. 2002).  
In addition to the GABA receptors, activation of local 5-HT3 receptors also appeared to 
be involved in mediating the reinforcing effects of ethanol, as suggested by the findings that co-
infusion of zacopride with ethanol dampened ethanol self-infusion into the NACsh. A previous 
study (Herges & Taylor 2000) showed that antagonism of 5-HT3 receptors within the NAC with 
ondansetron did not significantly alter basal locomotor activity. In addition, zacopride did not 
appear to alter responses on the inactive lever in the current study (Fig. 4). All these findings 
suggest that the effects of zacopride may not involve impairment of locomotor activity. This 
finding is in line with electrophysiological findings that ethanol can potentiate 5-HT3 receptor 
mediated currents in vitro (Lovinger and White 1991; Machu and Harris 1994). Our results 
provide mechanistic evidence supporting the involvement of activation of NACsh 5-HT3 
receptors in mediating systemic ethanol self-administration in rodents (Engleman et al. 2008; 
Knapp and Pohorecky 1992; McKinzie et al. 2000; Rodd-Henricks et al. 2000b). Interestingly, 
local 5-HT3 receptors within the VTA also seem to be involved in the reinforcing and rewarding 
effects of ethanol (Rodd-Henricks et al. 2003; Rodd et al. 2010). These studies suggest a close 
relationship between ethanol self-administration and 5-HT3 receptors within the mesolimbic 
system.      
Autoradiographic studies indicated that low to moderate densities of 5-HT3 receptor 
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binding sites were present in the NAC (Barnes et al. 1990; Ge et al. 1997; Kilpatrick et al. 1987). 
However, the relative cellular location and distribution in each NAC sub-region of these 
receptors remains unclear. In situ hybridization studies (Morales et al. 2004; Tecott et al. 1993) 
did not detect 5-HT3 receptor mRNA in the NAC, which agrees with an immunocytochemistry 
study showing that very low levels of 5-HT3 receptor-expressing cells were detected in the NAC 
(Morales et al. 1998). These studies suggest that these receptors may be preferentially localized 
on synaptic terminals as opposed to NAC MSNs. One likely possibility is on dopaminergic 
terminals. Microdialysis studies demonstrated that local perfusion of a 5-HT3 receptor agonist 
could increase basal and ethanol-evoked dopamine release in the NAC, whereas antagonizing 
local 5-HT3 receptors could attenuate ethanol-induced dopamine release in the NAC (Campbell 
and McBride 1995). In addition, systemic administration of 5-HT3 receptor antagonists was 
shown to attenuate ethanol-induced dopamine release in the NAC (Carboni et al. 1989; Wozniak 
et al. 1990). These findings suggest that 5-HT3 receptors on dopaminergic terminals may 
contribute to ethanol self-infusion and the effects of zacopride observed in the current study.  
In summary, the current study demonstrated that antagonism of local GABAA, GABAB or 
5-HT3 receptors attenuated ethanol self-infusion into the NACsh, suggesting that the local 
reinforcing effects of ethanol in the NACsh may be mediated by activation of these receptors. 
These results are consistent with previous findings and suggest these receptors within the NACsh 
may contribute to the global reinforcing and rewarding effects of ethanol. On the other hand, it 
remains unknown whether there are possible interactions among these different receptors and 
how they interact in mediating ethanol reinforcement, which warrants future studies.       
 
 
 15 
Acknowledgements 
This study was supported in part by NIH grants AA012262 and AA07611. The authors declare 
no conflict of interest. The content of this manuscript is solely the responsibility of the authors 
and does not necessarily represent the official views of the NIAAA or NIH. 
Declaration of conflicting interests 
The authors declare that there is no conflict of interest.   
 16 
Figure legend 
Figure 1: Representative placements of microinjection sites in the nucleus accumbens shell for 
the self-infusion of ethanol. For clarity purpose, the overlapping sites are not included. Circles 
represent sites within the nucleus accumbens shell and squares represent sites ventral to the 
nucleus accumbens shell.   
 
Figure 2: Effects of co-infusion of aCSF, 10 or 100 µM bicuculline (a GABAA receptor 
antagonist) with 150 mg% ethanol on lever responses for the intracranial self-infusion of ethanol 
into the nucleus accumbens shell (n = 6-7 / group). * p < 0.05, significantly higher responses 
than those on the inactive lever. # p < 0.05, significantly lower responses than the average 
responses on the active lever during acquisition sessions 3 and 4.   
 
Figure 3: Effects of co-infusion of 50, 75 or 100 µM SCH 50911 (a GABAB receptor antagonist) 
with 150 mg% ethanol on lever responses for the intracranial self-infusion of ethanol into the 
nucleus accumbens shell (n = 6 / group). * p < 0.05, significantly higher responses than those on 
the inactive lever. # p < 0.05, significantly lower responses than the average responses on the 
active lever during acquisition sessions 3 and 4. 
 
Figure 4: Effects of co-infusion of 10 or 100 µM zacopride (a 5-HT3 receptor antagonist) with 
150 mg% ethanol on lever responses for the intracranial self-infusion of ethanol into the nucleus 
accumbens shell (n = 6-7 / group). * p < 0.05, significantly higher responses than those on the 
inactive lever. # p < 0.05, significantly lower responses than the average responses on the active 
lever during acquisition sessions 3 and 4.    
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Table 1: Effects of co-infusion of an antagonist for the GABAA, 
GABAB or 5HT3 receptor with 150 mg% ethanol on number of infusions into the NACsh 
 
  
Group Sessions 3 & 4 Session 6 t value p value 
150 mg% EtOH + aCSF 24 ± 3 25 ± 3 0.3 0.76 
150 mg% ethanol + 10 µM bicuculline 23 ± 4 22 ± 4 0.4 0.72 
150 mg% ethanol + 100 µM 
bicuculline 17 ± 1 8 ± 2 5.6 0.002 
150 mg% ethanol + 50 µM SCH 50911 21 ± 4 19 ± 3 1.2 0.29 
150 mg% ethanol + 75 µM SCH 50911 18 ± 1 8 ± 1 8.0 < 0.001 
150 mg% ethanol + 100 µM SCH 
50911 22 ± 2 32 ± 5 1.6 0.16 
150 mg% ethanol + 10 µM zacopride 19 ± 2 14 ± 3 1.4 0.22 
150 mg% ethanol + 100 µM zacopride 17 ± 1 10 ± 1 17.0 < 0.001 
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